骨肉瘤化疗进展 |
摘要点击次数: 2218
全文下载次数: 1937
投稿时间:2006-04-20
|
作者 | Author | 单位 | Address | E-Mail |
梁鹏 |
LIANG Peng |
甘肃省肿瘤医院骨科,甘肃兰州730050 |
Department of Orthopaedics,the Cancer Hospital of Gansu,Lanzhou 730050,Gansu,China |
|
宋建民 |
SONG Jian-min |
甘肃省肿瘤医院骨科,甘肃兰州730050 |
Department of Orthopaedics,the Cancer Hospital of Gansu,Lanzhou 730050,Gansu,China |
|
|
期刊信息:《中国骨伤》2007年,第20卷,第1期,第67-69页 |
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz |
基金项目: |
|
中文摘要:化疗可杀灭骨肉瘤肺部微转移灶,提高5年存活率,并为保肢提供一个安全的边界,使许多患者得以保存肢体,提高患者生存质量;化疗耐药的出现对骨肉瘤化疗提出了新挑战,但化疗在骨肉瘤治疗中的地位尚无法替代。 |
【关键词】骨肉瘤 抗肿瘤联合化疗方案 微转移 |
|
Progression of osteosarcoma chemotherapy |
|
ABSTRACT Chemotherapy can kill the micrometastasis of osteosarcoma in lung,increase the 5-year survival rate and provide a safe verge for limb salvage,thus help many patients to reserve their limb and improve their quality of life.The chemotherapy-resistant give a new challenge for treating osteosarcoma,but nothing can substitute chemotherapy in treating osteosarcoma. |
KEY WORDS Osteosarcoma Antineoplastic combined chemotherapy protocols Micrometastasis |
|
引用本文,请按以下格式著录参考文献: |
中文格式: | 梁鹏,宋建民.骨肉瘤化疗进展[J].中国骨伤,2007,20(1):67~69 |
英文格式: | LIANG Peng,SONG Jian-min.Progression of osteosarcoma chemotherapy[J].zhongguo gu shang / China J Orthop Trauma ,2007,20(1):67~69 |
|
阅读全文 下载 查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|